LAUSR

Objectives The aims of the study were to develop and validate a machine learning classifier for preoperative prediction of tumor-infiltrating lymphocytes (TILs) in patients with pancreatic ductal adenocarcinoma (PDAC). Methods In this retrospective study of 183 PDAC patients who underwent multidetector computed tomography and surgical resection, CD4+, CD8+, and CD20+ expression was evaluated using immunohistochemistry, and TIL scores were calculated using the Cox regression model. The patients were divided into TIL-low and TIL-high groups. An extreme gradient boosting (XGBoost) classifier was developed using a training set consisting of 136 consecutive patients, and the model was validated in 47 consecutive patients. The discriminative ability, calibration, and clinical utility of the XGBoost classifier were evaluated. Results The prediction model showed good discrimination in the training (area under the curve, 0.93; 95% confidence interval, 0.89–0.97) and validation (area under the curve, 0.79; 95% confidence interval, 0.65–0.92) sets with good calibration. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for the training set were 0.93, 0.85, 0.90, 0.89, and 0.91, respectively, while those for the validation set were 0.63, 0.91, 0.77, 0.88, and 0.70, respectively. Conclusions The XGBoost-based model could predict PDAC TILs and may facilitate clinical decision making for immune therapy.